| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 01/09/2003 | US20030008815 For diagnosis and therapy of immune related disease in mammals, including humans; tumor therapy |
| 01/09/2003 | US20030008379 Novel 'pseudomonas stutzeri' strain and process for preparation of xylanase |
| 01/09/2003 | US20030008372 Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon |
| 01/09/2003 | US20030008371 Cloning and characterization of a human adenylyl cyclase |
| 01/09/2003 | US20030008370 Nucleotid sequences coding enzymatic polypeptide for use in the treatment of cancer |
| 01/09/2003 | US20030008369 Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases |
| 01/09/2003 | US20030008368 Serine O-acetytransferase |
| 01/09/2003 | US20030008366 Polypeptide for use in the treatment of inflammation |
| 01/09/2003 | US20030008365 Nucleotide sequences coding polypeptides for use in human therapeutics, diagnostics and pharmacology |
| 01/09/2003 | US20030008363 Gram-positive bacterium for use in the generation of ethanol |
| 01/09/2003 | US20030008360 Microorganisms for use in the generation of preferential cyclopentene |
| 01/09/2003 | US20030008359 Generation of isoleucine in bacteria; obtain nutrient broths, inoculate with bacteria, transform bacteria, express nuceotide sequences, recover isoleucine |
| 01/09/2003 | US20030008358 Method of producing L-serine by fermentation |
| 01/09/2003 | US20030008354 Peptide for use in the diagnosis and treatment of parkinson's, cancer and developmental defects |
| 01/09/2003 | US20030008353 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors |
| 01/09/2003 | US20030008352 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008347 Diagnosis and treatment of ALP related disorders |
| 01/09/2003 | US20030008345 Expression augmenting sequence elements (EASE) for eukaryotic expression systems |
| 01/09/2003 | US20030008327 Detecting phosphorylation in a polypeptide; obtain polypeptide, expose to spectrum analysis, compare ratio of phosphorous and sulfur, compare to control, adjustment in phosphorous indicates, phosphorylation |
| 01/09/2003 | US20030008324 Caspase-7-interacting protein and use thereof |
| 01/09/2003 | US20030008297 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2003 | US20030008291 Protein for use in diagnosis and treatment of cancer |
| 01/09/2003 | US20030007983 Two-hybrid assay that detects HIV-1 reverse transcriptase dimerization |
| 01/09/2003 | US20030007980 Urease-based vaccine and treatment for helicobacter infection |
| 01/09/2003 | US20030007975 Anticancer agents |
| 01/09/2003 | US20030007967 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/09/2003 | US20030007963 Treatment of pompe's disease |
| 01/09/2003 | CA2453864A1 A walk-through technique for in vitro recombination of polynucleotide sequences |
| 01/09/2003 | CA2452390A1 Use of tyrosine kinase inhibitors for treating bone loss |
| 01/09/2003 | CA2452029A1 A group of .alpha.-amylases and a method for identification and production of .alpha.-amylases |
| 01/09/2003 | CA2451957A1 Methods, vectors, cell lines and kits for selecting nucleic acids having a desired feature |
| 01/09/2003 | CA2451837A1 Structure-based drug design methods for identifying d-ala-d-ala ligase inhibitors as antibacterial drugs |
| 01/09/2003 | CA2451278A1 Methods and systems for identifying kinases, phosphatases and substrates thereof |
| 01/09/2003 | CA2450985A1 Polymer stabilized proteinases |
| 01/09/2003 | CA2429429A1 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method |
| 01/08/2003 | EP1273914A1 Hypotensors |
| 01/08/2003 | EP1273663A2 Transformed yeast strains and their use fore the production of monoterminal and diterminal aliphatic carboxylates |
| 01/08/2003 | EP1273662A2 Reversible nuclear genetic system for male sterility in transgenic plants |
| 01/08/2003 | EP1273661A2 Heliothis virescens (tobacco budworm) 26/29 cysteine protease and uses thereof |
| 01/08/2003 | EP1273654A1 BAD as substrate for PP2C |
| 01/08/2003 | EP1272663A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 01/08/2003 | EP1272656A1 Human serine racemase |
| 01/08/2003 | EP1272650A2 Maize cellulose synthases and uses thereof |
| 01/08/2003 | EP1272648A2 Process for modifying plants |
| 01/08/2003 | EP1272646A2 Regulation of human serine racemase enzyme |
| 01/08/2003 | EP1272645A1 Production of non-cariogenic sugars in transgenic plants |
| 01/08/2003 | EP1272644A1 Human metalloprotease and polynucleotides encoding the same |
| 01/08/2003 | EP1272643A1 Talaromyces emersonii beta-glucanases |
| 01/08/2003 | EP1272642A2 Coffee mannanase |
| 01/08/2003 | EP1272641A2 Serine-threonine kinase |
| 01/08/2003 | EP1272640A2 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor |
| 01/08/2003 | EP1272639A2 Genes encoding denitrification enzymes |
| 01/08/2003 | EP1272638A2 Drug metabolizing enzymes |
| 01/08/2003 | EP1272633A2 Compositions and methods for dendritic cell-based immunotherapy |
| 01/08/2003 | EP1272623A2 Novel subtilase enzymes having an improved wash performance on egg stains |
| 01/08/2003 | EP1272622A1 Method for modification of proteins by transglutaminase |
| 01/08/2003 | EP1272621A1 Plant anthocyanidin rutinoside aromatic acyl transferases |
| 01/08/2003 | EP1272620A2 Expression system for efficiently producing clinically effective glucocerebrosidase |
| 01/08/2003 | EP1272522A1 Selectable marker genes |
| 01/08/2003 | EP1272506A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 01/08/2003 | EP1272043A1 Enzyme composition for treatment of milk |
| 01/08/2003 | EP1272030A1 Methods for sexing non-human mammals |
| 01/08/2003 | EP1179074A4 Novel genes encoding wheat starch synthases and uses therefor |
| 01/08/2003 | EP1080189A4 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
| 01/08/2003 | EP0805857A4 Method for generating proteolytic enzymes specific against a selected peptide sequence |
| 01/08/2003 | EP0751996B1 Luciferases |
| 01/08/2003 | EP0728194B1 In situ modification and manipulation of stem cells of the central nervous system |
| 01/08/2003 | CN1390261A GMP synthetase derived from plants |
| 01/08/2003 | CN1390260A Expression of proteins in genetically modified fungi |
| 01/08/2003 | CN1390252A Fungamyl-like alpha-amylase variants |
| 01/08/2003 | CN1390232A Human beta-secretase enzyme, inhibitor, and its composition and use |
| 01/08/2003 | CN1390134A The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 01/08/2003 | CN1390089A Transgenic fiber producing plants with increased expression of sucrose phosphate synthase |
| 01/08/2003 | CN1389567A Ribonuclease extracting process |
| 01/08/2003 | CN1389442A Proteinase biocatalyst and its prepn. |
| 01/07/2003 | USRE37958 DNA sequence coding for protein C |
| 01/07/2003 | US6504083 Maize Gos-2 promoters |
| 01/07/2003 | US6504080 Transgenic animal model for neurodegenerative disorders |
| 01/07/2003 | US6503898 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection |
| 01/07/2003 | US6503888 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/07/2003 | US6503749 Yeast strains possessing the interrupted ATF2 gene and their applications |
| 01/07/2003 | US6503744 Prokaryotic glycosyltransferases, including a bifunctional sialyltransferase that has both an alpha 2,3- and an alpha 2,8-activity. A beta 1,4-GalNAc transferase and a beta 1,3-galactosyltransferase, gene expression vectors and cells |
| 01/07/2003 | US6503742 Ubiquitin ligases and uses related thereto |
| 01/07/2003 | US6503741 Polyketide synthase genes from Streptomyces venezuelae |
| 01/07/2003 | US6503737 Isolated nucleic acids relating to the fkbA gene within the FK-520 polyketide synthase gene cluster |
| 01/07/2003 | US6503731 Fibrin microbeads prepared from fibrinogen, thrombin and factor XIII for binding cells |
| 01/07/2003 | US6503700 Mammalian CDP-diacylglycerol synthase |
| 01/07/2003 | US6503508 Detergents |
| 01/07/2003 | US6503507 Oxygen activatable formulations for disinfection or sterilization |
| 01/07/2003 | CA2257581C Biodegradation of metal cyanides |
| 01/07/2003 | CA2198317C Method for preparing pancreatin which contains low amounts of residual organic solvent and product thereof |
| 01/07/2003 | CA2089666C Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/07/2003 | CA2076307C Orally-active elastase inhibitors |
| 01/07/2003 | CA2047531C 1-(substituted pyridinylamino)-1h-indol-5-yl substituted carbamates, a process and intermediates for their preparation and their use as medicaments |
| 01/06/2003 | CA2392549A1 Acetyl-coa carboxylase subunits |
| 01/03/2003 | WO2003000941A2 Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same |
| 01/03/2003 | WO2003000924A2 Endoglucanases, nucleic acids encoding them and methods for making and using them |
| 01/03/2003 | WO2003000921A2 Alpha galactosides, nucleic acids encoding them and methods for making and using them |
| 01/03/2003 | WO2003000912A1 A process for the preparation of gallic acid by co-culture |
| 01/03/2003 | WO2003000906A2 Plant disease resistance genes |